Amgen Inc (AMGN)

The California-based Amgen is a biotechnology firm that makes drugs aimed at battling anemia, blood disorders, and cancer by attacking the source of the disease - the genes.

Show Chart

Events

  • September142010
    Amgen Inc. Presents at 2010 PDA/FDA Joint Regulatory Conference, Sep-13-2010 through Sep-16-2010
  • September152010
    Amgen Inc. Presents at 2nd Annual World PharmaTrials Asia 2010, Sep-15-2010 10:00 AM
  • September202010
    Amgen Inc. Presents at 7th Annual Forum on Formulary and Reimbursement Strategies for Effective Product Planning, Sep-20-2010 02:00 PM
  • September282010
    Amgen Inc. Presents at 7th MSL Best Practices, Sep-28-2010 01:45 PM
  • October292010
    Amgen Inc. expected to report Q3 2010 results on October 29, 2010. This event was calculated by Capital IQ (Created on July 31, 2010).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $-0.08 (-0.15%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed